Shaping the future of diagnostics.

MicroPhage is developing a portfolio of products that address the urgent clinical needs.

• MRSA/MSSA Screening
• Skin and Soft Tissue Infections
• Clindamycin Resistance
• Vancomycin Tolerance
• Urinary Tract Infections
• Respiratory Infections

If you are interested in receiving updates on our research, technology, and products, please subscribe to our newsletter.